Severe neutropenia in prolonged treatment with orally administered Augmentin (amoxicillin/clavulanic acid)
Desgrandchamps
D
D
Schnyder
C
C
D000284:Administration, Oral; D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced*; D000658:Amoxicillin / Q000008:administration & dosage / Q000009:adverse effects*; D019980:Amoxicillin-Potassium Clavulanate Combination; D002969:Clavulanic Acids / Q000008:administration & dosage / Q000009:adverse effects*; D004338:Drug Combinations / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D008297:Male; D009503:Neutropenia / Q000139:chemically induced*
D002969:Clavulanic Acids; D004338:Drug Combinations; D019980:Amoxicillin-Potassium Clavulanate Combination; D000658:Amoxicillin